Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Chinese Patent Office
Federal Trade Commission

Generated: April 20, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065157

« Back to Dashboard

NDA 065157 describes PIPERACILLIN, which is a drug marketed by Istituto Bio Ita Spa, Apollo Pharms Inc, Aurobindo Pharma Ltd, Fresenius Kabi, Fresenius Kabi Usa, Hospira Inc, Mylan Labs Ltd, Qilu Tianhe, Sandoz, Sandoz Inc, and Wockhardt Bio Ag, and is included in nineteen NDAs. Additional details are available on the PIPERACILLIN profile page.

The generic ingredient in PIPERACILLIN is piperacillin sodium; tazobactam sodium. There are sixteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the piperacillin sodium; tazobactam sodium profile page.
Summary for 065157
Applicant:Istituto Bio Ita Spa
Ingredient:piperacillin sodium
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 065157

Profile for product number 001

Approval Date:Jul 12, 2004TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.